EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL

被引：0
|
作者：
Lee, Scott D.
Schreiber, Stefan
Janneke, Christien
Van der Woude
Marin-Jimenez, Ignacio
Wolf, Douglas C.
Schnoy, Elisabeth
Salzberg, Bruce
Busse, Christopher
Nazar, Maciej
Langholff, Wayne
Borghorst, Stephan
Gasink, Christopher
Baker, Thomas
Godwin, Bridget
Feagan, Brian G.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1027
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [41] Efficacy of Intravenous Ustekinumab as Induction Therapy for Patients Hospitalized With Severe Inflammatory Bowel Disease: A Case Series
    Hooper, Alexander
    Matro, Rebecca
    Coyle, Walter
    Rosenblatt, Angela
    Konijeti, Gauree G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1200 - S1201
  • [42] Efficacy of intravenous ustekinumab maintenance treatment in patients with Inflammatory Bowel Disease with partial response or loss of response to subcutaneous ustekinumab: A single centre, observational, retrospective study
    Pesantes, V. C. Jarrin
    Lozano, O. Moralejo
    Tercero, M. Abanades
    Perez, L. Ruano
    Luque, R. Salmoral
    Rosas, C. Munoz
    Rodriguez, R. A. Gomez
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1926 - i1928
  • [43] Ustekinumab Versus Adalimumab for Induction and Maintenance Therapy in Moderate-to-Severe Crohn's Disease: The SEAVUE Study
    Sands, Bruce E.
    Irving, Peter M.
    Hoops, Timothy
    Izanec, James L.
    Gao, Long-Long
    Gasink, Christopher
    Greenspan, Andrew
    Allez, Matthieu
    Danese, Silvio
    Hanauer, Stephen B.
    Jairath, Vipul
    Kuehbacher, Tanja
    Lewis, James D.
    Loftus, Edward V.
    Mihaly, Emese
    Panaccione, Remo
    Scherl, Ellen J.
    Shchukina, Oksana
    Sandborn, William J.
    GASTROENTEROLOGY, 2021, 161 (02) : E30 - E31
  • [44] RE-induction and maintenance therapy with subcutaneous certolizumab pegial in patients with Crohn's disease following treatment failure: Precise 4 results
    Sandborn, William J.
    Hanauer, Stephen B.
    Rutgeerts, Paul J.
    Colombel, Jean-frederic
    Schreiber, Stefan
    GASTROENTEROLOGY, 2007, 132 (04) : A505 - A505
  • [45] Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn's disease: Week 16 interim analysis of the STARDUST trial substudy
    Kucharzik, T.
    Wilkens, R.
    Maconi, G.
    D'Agostino, M. A.
    Le Bars, M.
    Nazar, M.
    Sloan, S.
    Lahaye, M.
    Ni, L.
    Ercole, E.
    Alloca, M.
    Machkova, N.
    Maaser, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S046 - S048
  • [46] INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL HEALING AFTER USTEKINUMAB INDUCTION IN CROHN'S DISEASE: WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL SUBSTUDY
    Kucharzik, Torsten
    Wilkens, Rune
    Maconi, Giovanni
    D'Agostino, Maria-Antonietta
    Le Bars, Manuela
    Nazar, Maciej
    Sloan, Sheldon
    Lahaye, Marjolein
    Ni, Lioudmila
    Ercole, Elena
    Allocca, Mariangela
    Machkova, Nadezda
    Maaser, Christian
    GASTROENTEROLOGY, 2020, 158 (06) : S61 - S61
  • [47] Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis
    Chenna, Venkata Sai Harshabhargav
    Nagi, Talwinder K.
    Suarez, Zoilo K.
    Hernandez, Oscar L.
    Nageye, Maymona E.
    Reyaz, Nafisa
    Reyaz, Ibrahim
    Ali, Neelum
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [48] Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients
    Doherty, Matthew K.
    Ding, Tao
    Koumpouras, Charlie
    Telesco, Shannon E.
    Monast, Calixte
    Das, Anuk
    Brodmerkel, Carrie
    Schloss, Patrick D.
    MBIO, 2018, 9 (02):
  • [49] EFFICACY OF DIFFERENT USTEKINUMAB MAINTENANCE REGIMENS IN PATIENTS WITH CROHN'S DISEASE WITH PRIOR THERAPY USING GENETICALLY ENGINEERED BIOLOGICAL DRUGS
    Knyazev, O. V.
    Kagramanova, A. V.
    Lishchinskaya, A. A.
    Nanaeva, B. A.
    Fadeeva, N. A.
    Zvyaglova, M. Yu.
    Shkurko, T. V.
    Zhulina, E. Yu.
    Parfenov, A. I.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (02) : 319 - 320
  • [50] Letter: optimising response to ustekinumab therapy for patients with Crohn's disease-author's reply
    Kopylov, Uri
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 907 - 907
12345